{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:21:16Z","timestamp":1778203276937,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsche Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>Investigation of the current practice of diagnostics and treatment in pediatric cancer patients with febrile neutropenia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>On behalf of the German Society for Pediatric Oncology and Hematology and the German Society for Pediatric Infectious Diseases, an Internet-based survey was conducted in 2016 concerning the management of febrile neutropenia in pediatric oncology centers (POC). This survey accompanied the release of the corresponding German guideline to document current practice before its implementation in clinical practice.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In total, 51 POCs participated (response rate 73%; 43 from Germany, and 4 each from Austria and Switzerland). Identified targets for antimicrobial stewardship concerned blood culture diagnostics, documentation of the time to antibiotics, the use of empirical combination therapy, drug monitoring of aminoglycosides, the time to escalation in patients with persisting fever, minimal duration of IV treatment, sequential oral treatment in patients with persisting neutropenia, indication for and choice of empirical antifungal treatment, and the local availability of a pediatric infectious diseases consultation service.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This survey provides useful information for local antibiotic stewardship teams to improve the current practice referring to the corresponding national and international guidelines.<\/jats:p>\n<\/jats:sec>","DOI":"10.1007\/s15010-020-01462-z","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T15:03:57Z","timestamp":1591801437000},"page":"607-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland"],"prefix":"10.1007","volume":"48","author":[{"given":"Max","family":"Scheler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Volland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Laws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland A.","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Agyeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaux","family":"Lux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9558-3330","authenticated-orcid":false,"given":"Arne","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"1462_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/mop.0000000000000708","volume":"31","author":"T Lehrnbecher","year":"2019","unstructured":"Lehrnbecher T. Treatment of fever in neutropenia in pediatric oncology patients. Curr Opin Pediatr. 2019;31:35\u201340. https:\/\/doi.org\/10.1097\/mop.0000000000000708.","journal-title":"Curr Opin Pediatr"},{"key":"1462_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26397","author":"M Af-Sandeberg","year":"2017","unstructured":"Af-Sandeberg M, Johansson E, Wettergren L, Bjork O, Hertting O, Nilsson A. Antibiotic use during infectious episodes in the first 6 months of anticancer treatment-A Swedish cohort study of children aged 7\u201316 years. Pediatr Blood Cancer. 2017. https:\/\/doi.org\/10.1002\/pbc.26397.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/archdischild-2013-303810","volume":"98","author":"J Bate","year":"2013","unstructured":"Bate J, Gibson F, Selwood K, Skinner R, Phillips B, Chisholm JC. A reaudit of current febrile neutropenia practice in UK paediatric oncology centres prior to implementation of NICE guidance. Arch Dis Child. 2013;98:315\u20136. https:\/\/doi.org\/10.1136\/archdischild-2013-303810.","journal-title":"Arch Dis Child"},{"key":"1462_CR4","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/pbc.26121","volume":"63","author":"M Delebarre","year":"2016","unstructured":"Delebarre M, Tiphaine A, Martinot A, Dubos F. Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: results of a French nationwide survey. Pediatr Blood Cancer. 2016;63:2167\u201372. https:\/\/doi.org\/10.1002\/pbc.26121.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR5","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.3109\/10428194.2012.750722","volume":"54","author":"BT Fisher","year":"2013","unstructured":"Fisher BT, Gerber JS, Leckerman KH, Seif AE, Huang YS, Li Y, et al. Variation in hospital antibiotic prescribing practices for children with acute lymphoblastic leukemia. Leuk Lymphoma. 2013;54:1633\u20139. https:\/\/doi.org\/10.3109\/10428194.2012.750722.","journal-title":"Leuk Lymphoma"},{"key":"1462_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/1043454213514793","volume":"31","author":"A Cox","year":"2014","unstructured":"Cox A, Bradford N. Management of febrile neutropenia in pediatric oncology across Queensland, Australia: a retrospective review on variations between locations. J Pediatr Oncol Nurs. 2014;31:28\u201333. https:\/\/doi.org\/10.1177\/1043454213514793.","journal-title":"J Pediatr Oncol Nurs"},{"key":"1462_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26700","author":"RR Maxwell","year":"2017","unstructured":"Maxwell RR, Egan-Sherry D, Gill JB, Roth ME. Management of chemotherapy-induced febrile neutropenia in pediatric oncology patients: A North American survey of pediatric hematology\/oncology and pediatric infectious disease physicians. Pediatr Blood Cancer. 2017. https:\/\/doi.org\/10.1002\/pbc.26700.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/jpc.13899","volume":"54","author":"GM Haeusler","year":"2018","unstructured":"Haeusler GM, Slavin MA, Bryant PA, Babl FE, Mechinaud F, Thursky KA. Management of fever and neutropenia in children with cancer: a survey of Australian and New Zealand practice. J Paediatr Child Health. 2018;54:761\u20139. https:\/\/doi.org\/10.1111\/jpc.13899.","journal-title":"J Paediatr Child Health"},{"key":"1462_CR9","unstructured":"Deutsche Gesellschaft f\u00fcr p\u00e4diatrische Infektiologie (DGPI), Gesellschaft f\u00fcr P\u00e4diatrische Onkologie und H\u00e4matologie (GPOH). Diagnostik und Therapie bei Kindern mit onkologischer Grunderkrankung, Fieber und Granulozytopenie (mit febriler Neutropenie) au\u00dferhalb der allogenen Stammzelltransplantation. Arbeitsgemeinschaft Wissenschaftlicher Fachgesellschaften (AWMF). 2016;Registernummer 048\/14(Finale Version 23.01.2016)."},{"key":"1462_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3324\/haematol.2011.048918","volume":"97","author":"S Livadiotti","year":"2012","unstructured":"Livadiotti S, Milano GM, Serra A, Folgori L, Jenkner A, Castagnola E, et al. A survey on hematology-oncology pediatric AIEOP centers: prophylaxis, empirical therapy and nursing prevention procedures of infectious complications. Haematologica. 2012;97:147\u201350. https:\/\/doi.org\/10.3324\/haematol.2011.048918.","journal-title":"Haematologica"},{"key":"1462_CR11","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/jco.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35:2082\u201394. https:\/\/doi.org\/10.1200\/jco.2016.71.7017.","journal-title":"J Clin Oncol"},{"key":"1462_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-0044-101953","volume":"230","author":"T Lehrnbecher","year":"2018","unstructured":"Lehrnbecher T, Groll A, Agyeman P, Ammann RA, Attarbaschi A, Behrends U, et al. Recommendations for diagnostics and therapy of children with cancer presenting with fever and neutropenia\u2014comparison of two current guidelines. Klin Padiatr. 2018;230:115\u201321. https:\/\/doi.org\/10.1055\/s-0044-101953.","journal-title":"Klin Padiatr"},{"key":"1462_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/pbc.24662","volume":"60","author":"GM Haeusler","year":"2013","unstructured":"Haeusler GM, Phillips RS, Lehrnbecher T, Sung L, Ammann RA. The reporting of outcomes in studies of fever and neutropenia in children with cancer: time for consensus. Pediatr Blood Cancer. 2013;60:1563\u20134. https:\/\/doi.org\/10.1002\/pbc.24662.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pbc.25335","volume":"62","author":"GM Haeusler","year":"2015","unstructured":"Haeusler GM, Phillips RS, Lehrnbecher T, Thursky KA, Sung L, Ammann RA. Core outcomes and definitions for pediatric fever and neutropenia research: a consensus statement from an international panel. Pediatr Blood Cancer. 2015;62:483\u20139. https:\/\/doi.org\/10.1002\/pbc.25335.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/pbc.24380","volume":"60","author":"P Binz","year":"2013","unstructured":"Binz P, Bodmer N, Leibundgut K, Teuffel O, Niggli FK, Ammann RA. Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: a retrospective two-center cohort study. Pediatr Blood Cancer. 2013;60:799\u2013805. https:\/\/doi.org\/10.1002\/pbc.24380.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/mph.0000000000001718","author":"C Barking","year":"2020","unstructured":"Barking C, Masjosthusmann K, Rellensmann G, Ehlert K, Zollner S, Jocham S, et al. Treatment of children with cancer and\/or hematopoietic stem cell transplantation in the intensive care unit: experience at a large European pediatric cancer center. J Pediatr Hematol Oncol. 2020. https:\/\/doi.org\/10.1097\/mph.0000000000001718.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1462_CR17","first-page":"545","volume":"22","author":"AH Gaur","year":"2003","unstructured":"Gaur AH, Giannini MA, Flynn PM, Boudreaux JW, Mestemacher MA, Shenep JL, et al. Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume. Pediatr Infect Dis J. 2003;22:545\u201352.","journal-title":"Pediatr Infect Dis J"},{"key":"1462_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1128\/jcm.02919-15","volume":"54","author":"J Dien Bard","year":"2016","unstructured":"Dien Bard J, McElvania TE. Diagnosis of bloodstream infections in children. J Clin Microbiol. 2016;54:1418\u201324. https:\/\/doi.org\/10.1128\/jcm.02919-15.","journal-title":"J Clin Microbiol"},{"key":"1462_CR19","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/pbc.25965","volume":"63","author":"LA Petty","year":"2016","unstructured":"Petty LA, Sokol EA, Bartlett AH, McNeer JL, Alexander KA, Pisano J. Repeated blood cultures in pediatric febrile neutropenia: would following the guidelines alter the outcome? Pediatr Blood Cancer. 2016;63:1244\u20139. https:\/\/doi.org\/10.1002\/pbc.25965.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/jpids\/piu145","volume":"5","author":"K Neemann","year":"2016","unstructured":"Neemann K, Yonts AB, Qiu F, Simonsen K, Lowas S, Freifeld A. Blood cultures for persistent fever in neutropenic pediatric patients are of low diagnostic yield. J Pediatr Infect Dis Soc. 2016;5:218\u201321. https:\/\/doi.org\/10.1093\/jpids\/piu145.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"1462_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/pbc.24358","volume":"60","author":"J Rosenblum","year":"2013","unstructured":"Rosenblum J, Lin J, Kim M, Levy AS. Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative. Pediatr Blood Cancer. 2013;60:923\u20137. https:\/\/doi.org\/10.1002\/pbc.24358.","journal-title":"Pediatr Blood Cancer"},{"key":"1462_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/bjc.2016.28","volume":"114","author":"RS Phillips","year":"2016","unstructured":"Phillips RS, Sung L, Amman RA, Riley RD, Castagnola E, Haeusler GM, et al. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer. 2016;114:623\u201330. https:\/\/doi.org\/10.1038\/bjc.2016.28.","journal-title":"Br J Cancer"},{"key":"1462_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00520-019-04961-4","volume":"28","author":"C Koenig","year":"2020","unstructured":"Koenig C, Schneider C, Morgan JE, Ammann RA, Sung L, Phillips B. Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review. Support Care Cancer. 2020;28:1369\u201383. https:\/\/doi.org\/10.1007\/s00520-019-04961-4.","journal-title":"Support Care Cancer"},{"key":"1462_CR24","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","volume":"30","author":"T Lehrnbecher","year":"2012","unstructured":"Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2012;30:4427\u201338. https:\/\/doi.org\/10.1200\/JCO.2012.42.7161.","journal-title":"J Clin Oncol"},{"key":"1462_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-017-0988-1","author":"D Averbuch","year":"2017","unstructured":"Averbuch D, Avaky C, Harit M, Stepensky P, Fried I, Ben-Ami T, et al. Non-fermentative Gram-negative rods bacteremia in children with cancer: a 14-year single-center experience. Infection. 2017. https:\/\/doi.org\/10.1007\/s15010-017-0988-1.","journal-title":"Infection"},{"key":"1462_CR26","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3324\/haematol.2013.091330","volume":"98","author":"D Averbuch","year":"2013","unstructured":"Averbuch D, Cordonnier C, Livermore DM, Mikulska M, Orasch C, Viscoli C, et al. Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica. 2013;98:1836\u201347. https:\/\/doi.org\/10.3324\/haematol.2013.091330.","journal-title":"Haematologica"},{"key":"1462_CR27","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/cid\/civ003","volume":"60","author":"PD Tamma","year":"2015","unstructured":"Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia. Clin Infect Dis. 2015;60:1319\u201325. https:\/\/doi.org\/10.1093\/cid\/civ003.","journal-title":"Clin Infect Dis"},{"key":"1462_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00431-015-2525-5","volume":"174","author":"RA Ammann","year":"2015","unstructured":"Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O, Dilloo D, et al. Bloodstream infection in paediatric cancer centres-leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr. 2015;174:675\u201386. https:\/\/doi.org\/10.1007\/s00431-015-2525-5.","journal-title":"Eur J Pediatr"},{"key":"1462_CR29","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00520-013-1797-4","volume":"21","author":"KG Miedema","year":"2013","unstructured":"Miedema KG, Winter RH, Ammann RA, Droz S, Spanjaard L, de Bont ES, et al. Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia\u2013species distribution and susceptibility patterns. Support Care Cancer. 2013;21:2417\u201326. https:\/\/doi.org\/10.1007\/s00520-013-1797-4.","journal-title":"Support Care Cancer"},{"key":"1462_CR30","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1200\/jco.2015.65.8591","volume":"34","author":"PD Robinson","year":"2016","unstructured":"Robinson PD, Lehrnbecher T, Phillips R, Dupuis LL, Sung L. Strategies for empiric management of pediatric fever and neutropenia in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review of randomized trials. J Clin Oncol. 2016;34:2054\u201360. https:\/\/doi.org\/10.1200\/jco.2015.65.8591.","journal-title":"J Clin Oncol"},{"key":"1462_CR31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/archdischild-2015-310294","volume":"101","author":"F Herd","year":"2016","unstructured":"Herd F, Bate J, Chisholm J, Johnson E, Phillips B. Variation in practice remains in the UK management of paediatric febrile neutropenia. Arch Dis Child. 2016;101:410\u20131. https:\/\/doi.org\/10.1136\/archdischild-2015-310294.","journal-title":"Arch Dis Child"},{"key":"1462_CR32","first-page":"141","volume":"42","author":"CA Pereira","year":"2009","unstructured":"Pereira CA, Petrilli AS, Carlesse FA, Luisi FA, da Silva KV, de Martino Lee ML. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison. J Microbiol Immunol Infect. 2009;42:141\u20137.","journal-title":"J Microbiol Immunol Infect"},{"key":"1462_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/archdischild-2015-309069","volume":"102","author":"E Germovsek","year":"2017","unstructured":"Germovsek E, Barker CI, Sharland M. What do I need to know about aminoglycoside antibiotics? Arch Dis Child Educ Pract Ed. 2017;102:89\u201393. https:\/\/doi.org\/10.1136\/archdischild-2015-309069.","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"1462_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00431-016-2691-0","volume":"175","author":"M Houot","year":"2016","unstructured":"Houot M, Pilmis B, Thepot-Seegers V, Suard C, Potier C, Postaire M, et al. Aminoglycoside use in a pediatric hospital: there is room for improvement-a before\/after study. Eur J Pediatr. 2016;175:659\u201365. https:\/\/doi.org\/10.1007\/s00431-016-2691-0.","journal-title":"Eur J Pediatr"},{"key":"1462_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/INF.0b013e318245ab48","volume":"31","author":"L Sung","year":"2011","unstructured":"Sung L, Manji A, Beyene J, Dupuis LL, Alexander S, Phillips R, et al. Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials. Pediatr Infect Dis J. 2011;31:431\u20135. https:\/\/doi.org\/10.1097\/INF.0b013e318245ab48.","journal-title":"Pediatr Infect Dis J"},{"key":"1462_CR36","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00520-012-1425-8","volume":"20","author":"A Manji","year":"2012","unstructured":"Manji A, Beyene J, Dupuis LL, Phillips R, Lehrnbecher T, Sung L. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children\u2013a systematic review of prospective trials. Support Care Cancer. 2012;20:1135\u201345. https:\/\/doi.org\/10.1007\/s00520-012-1425-8.","journal-title":"Support Care Cancer"},{"key":"1462_CR37","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s00520-016-3074-9","volume":"24","author":"JE Morgan","year":"2016","unstructured":"Morgan JE, Cleminson J, Atkin K, Stewart LA, Phillips RS. Systematic review of reduced therapy regimens for children with low risk febrile neutropenia. Support Care Cancer. 2016;24:2651\u201360. https:\/\/doi.org\/10.1007\/s00520-016-3074-9.","journal-title":"Support Care Cancer"},{"key":"1462_CR38","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1093\/annonc\/mdq745","volume":"22","author":"O Teuffel","year":"2011","unstructured":"Teuffel O, Ethier MC, Alibhai SM, Beyene J, Sung L. Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis. Ann Oncol. 2011;22:2358\u201365. https:\/\/doi.org\/10.1093\/annonc\/mdq745.","journal-title":"Ann Oncol"},{"key":"1462_CR39","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/s1470-2045(14)70017-8","volume":"15","author":"AH Groll","year":"2014","unstructured":"Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15:e327\u2013e340340. https:\/\/doi.org\/10.1016\/s1470-2045(14)70017-8.","journal-title":"Lancet Oncol"},{"key":"1462_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s40262-016-0379-2","volume":"55","author":"RS Kadam","year":"2016","unstructured":"Kadam RS, Van Den Anker JN. Pediatric clinical pharmacology of voriconazole: role of pharmacokinetic\/pharmacodynamic modeling in pharmacotherapy. Clin Pharmacokinet. 2016;55:1031\u201343. https:\/\/doi.org\/10.1007\/s40262-016-0379-2.","journal-title":"Clin Pharmacokinet"},{"key":"1462_CR41","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1086\/677624","volume":"35","author":"JM Mehta","year":"2014","unstructured":"Mehta JM, Haynes K, Wileyto EP, Gerber JS, Timko DR, Morgan SC, et al. Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol. 2014;35:1092\u20139. https:\/\/doi.org\/10.1086\/677624.","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01462-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-020-01462-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-020-01462-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T23:54:36Z","timestamp":1623282876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-020-01462-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1007\/s15010-020-01462-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AS is the second chairman of the DGPI and the coordinator of the German AWMF FN Guideline (Reg. No 048\/14). TL is the Chairman of the Working Group on Infectious complications in children with cancer of the GPOH and the working group Febrile Neutropenia of the DGPI. TL has received research grants from Gilead Sciences, is a consultant to Astellas, Basilea, Gilead Sciences, and Merck\/MSD, and served at the speaker\u00b4s bureau of Astellas, Gilead Sciences, Merck\/MSD, and Sanofi Pasteur. AHG has received research grants from Gilead, Merck, Sharp & Dohme, Pfizer; is\/has been a consultant to Amplyx, Astellas, Basilea, F2G, Gilead, Merck, Sharp & Dohme, Pfizer, Schering-Plough, Scynexis; and is\/has been on the speaker\u2019s bureau of Astellas, Basilea, F2G, Gilead, Merck, Sharp & Dohme, Pfizer, Schering-Plough and Zeneus\/Cephalon.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}